Videos / Enteric coated risedronate 35mg for the treatment of osteoporosis
In this Product Explainer, Endocrinologist Prof Ego Seeman explains the role of enteric coated risedronate 35mg for the treatment of osteoporosis (5 mins).
Endometriosis Cases – Practical Guide
Familial Colorectal Cancer
Recurrent Nasal Polyps Management – When to Refer
SUDEP – What is it and How to Reduce the Risk
expert
Endocrinologist; Dept of Medicine and Endocrinology, Austin Health, University of Melbourne; Editor, Progress in Osteoporosis